Today's Hours: 8:00am - 6:00pm

Search

Filter Applied Clear All

Did You Mean:

Search Results

  • Book
    edited by Daniel W. Lee, Nirali N. Shah.
    Contents:
    Introduction
    When to refer a patient for CAR-T cell therapy
    Optimizing the apheresis product
    CAR T cells: cell processing laboratory considerations
    Peri-CAR-T cell management
    Management of cytokine release syndrome
    Special considerations for ICU management of patients receiving CAR therapy
    Neurotoxicities after CAR-T cell immunotherapy
    Hematologic and non-CRS toxicities
    Response assessment and post-CAR-T cell therapy management
    Relapse management and role for consolidative hematopoietic stem cell transplantation following CAR-T cell therapy
    Promising chimeric antigen receptors for non-B cell hematological malignancies, pediatric solid tumors, and carcinomas
    CAR T cell therapy for CNS malignancies
    CAR 2.0: the next generation of synthetic receptor-based cellular therapy for cancer.
    Digital Access ClinicalKey 2020